699O - Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers
Published date:
09/19/2020
Excerpt:
In pts with elevated immune gene expression signatures, lower TGFb expression was associated with greater OS benefit with avelumab.